However, in a sensitivity analysis of the REWIND study with dulaglutide, the relative risk reduction for a 40% or 50% decrease in eGFR was 30% and 44%, both significant, in the dulaglutide group compared to placebo, respectively.92 This lower risk of developing macroalbuminuria was also confirmed in an exploratory analysis of the ELIXA (lixisenatide) study.93 In the EXSCEL study (exenatide LAR), renal episodes were analyzed as additional microvascular episodes, and no differences were observed in the risk of episodes related to decreased eGFR, but differences were observed in the composite episode, which included decreased eGFR and macroalbuminuria, although only after adjustment94 (Table 2)
, -1 -1 - - , , [6]
Leftover makeup will clog pores, contributing to skin irritation and breakouts
GLP-1 weight loss medications may be effective for some individuals in reducing excess weight
On a compounded medication, you are looking for the Beyond-Use Date or BUD. This is usually printed clearly on the prescription label provided by the pharmacy, often near the date filled. If the label is smudged or hard to read, you can call the pharmacy listed on the vial to ask for the BUD associated with your prescription number